סברילן
Country: Israel
Language: Hebrew
Source: Ministry of Health
Patient Information leaflet
(PIL)
03-01-2023
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
VIGABATRIN
Available from:
PADAGIS ISRAEL PHARMACEUTICALS LTD, ISRAEL
ATC code:
N03AG04
Pharmaceutical form:
טבליות מצופות פילם
Composition:
VIGABATRIN 500 MG
Administration route:
פומי
Prescription type:
מרשם נדרש
Manufactured by:
PADAGIS ISRAEL PHARMACEUTICALS LTD, ISRAEL
Therapeutic group:
VIGABATRIN
Therapeutic area:
VIGABATRIN
Therapeutic indications:
Treatment in combination with other anti epileptic drugs for patients with resistant partial epilepsy with or without secondary generalisation, that is where all other appropriate drug combinations have proven inadeqate or have not been tolerated.
Authorization date:
2022-10-31
